For years, cardiovascular patients have been taking anti-platelet medications to prevent life-threatening adverse cardiovascular events such as heart attacks, strokes and stent occlusions—without knowing whether their therapies were effective.

ThromboVision has developed a new medical device – the ThromboVision ThromboGuideTM (T-GuideTM) platelet therapy monitoring system.  This device provides a simple, inexpensive solution to help physicians and their patients monitor and assess anti-platelet therapies.  The T-Guide measures platelet aggregation using a patented light scattering technology which identifies and monitors the function of platelets and how they are affected by anti-platelet drugs such as aspirin (ASA) and clopidogrel (Plavix®).

Edward Teitel, MD

(713) 491-4449
Visit ThromboVision